secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001157523-23-000819
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Q1 revenue $1.03B, +12.6% YoY; raises organic growth guidance to 5.0-7.5%
--------------------------------------------------------------------------------

- GAAP EPS $2.01 (+11% YoY); non-GAAP EPS $2.78 (+1.1% YoY); net income $103.1M.
- DSA segment revenue $662.4M (+23.6% organic); non-GAAP operating margin 29.0%.
- Manufacturing segment revenue $167.3M (-1.8% organic); non-GAAP operating margin 13.7%.
- 2023 guidance narrowed: organic revenue growth 5.0-7.5% (prior 4.5-7.5%); non-GAAP EPS $9.90-$10.90.
- Management cites strong DSA demand but warns Cambodian NHP supply constraints will affect H2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000115752323000819/0001157523-23-000819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000115752323000819/a53397649.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-000819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer